{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:51:46Z","timestamp":1790815906589,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ecl.2011.01.012","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T12:12:46Z","timestamp":1305202366000},"page":"333-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Glucocorticoid-remediable Aldosteronism"],"prefix":"10.1016","volume":"40","author":[{"given":"Florencia","family":"Halperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Dluhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.ecl.2011.01.012_bib1","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"issue":"7","key":"10.1016\/j.ecl.2011.01.012_bib2","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","article-title":"Glucocorticoid-remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree","volume":"87","author":"Mulatero","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2011.01.012_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","article-title":"Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase","volume":"2","author":"Lifton","year":"1992","journal-title":"Nat Genet"},{"issue":"17","key":"10.1016\/j.ecl.2011.01.012_bib4","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","article-title":"Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2011.01.012_bib5","first-page":"64","article-title":"The molecular basis of glucocorticoid-remediable aldosteronism, a mendelian cause of human hypertension","volume":"105","author":"Lifton","year":"1992","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.ecl.2011.01.012_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.2002.tb04414.x","article-title":"New genetic insights in familial hyperaldosteronism","volume":"970","author":"Jackson","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.ecl.2011.01.012_bib7","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2011.01.012_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ndt\/gfl706","article-title":"A\u00a0German family with glucocorticoid-remediable aldosteronism","volume":"22","author":"Vonend","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2011.01.012_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/07435809509030463","article-title":"Clinical, biochemical and genetic features of five extended kindred\u2019s with glucocorticoid-suppressible hyperaldosteronism","volume":"21","author":"Jamieson","year":"1995","journal-title":"Endocr Res"},{"issue":"4","key":"10.1016\/j.ecl.2011.01.012_bib10","first-page":"255","article-title":"Dexamethasone-suppressible hyperaldosteronism: a large new kindred","volume":"3","author":"O\u2019Mahony","year":"1989","journal-title":"J\u00a0Hum Hypertens"},{"issue":"1","key":"10.1016\/j.ecl.2011.01.012_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.jhh.1001636","article-title":"Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism","volume":"18","author":"Fallo","year":"2004","journal-title":"J\u00a0Hum Hypertens"},{"issue":"7","key":"10.1016\/j.ecl.2011.01.012_bib12","first-page":"979","article-title":"Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism","volume":"115","author":"Ding","year":"2002","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.ecl.2011.01.012_bib13","first-page":"52","article-title":"Glucocorticoid-remediable aldosteronism: a case report","volume":"20","author":"Hsieh","year":"1997","journal-title":"Changgeng Yi Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.ecl.2011.01.012_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1291\/hypres.24.589","article-title":"Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction","volume":"24","author":"Yokota","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ecl.2011.01.012_bib15","article-title":"A\u00a0de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes Familial Hyperaldosteronism type I","author":"Carvajal","year":"2010","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.ecl.2011.01.012_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","article-title":"Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood","volume":"138","author":"Dluhy","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ecl.2011.01.012_bib17","first-page":"2160","article-title":"Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance","volume":"85","author":"Stowasser","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2011.01.012_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ecl.2011.01.012_bib19","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1210\/jcem.84.12.6256","article-title":"Glucocorticoid-remediable aldosteronism","volume":"84","author":"Dluhy","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2011.01.012_bib20","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2011.01.012_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10741-005-2346-0","article-title":"Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation","volume":"10","author":"Joffe","year":"2005","journal-title":"Heart Fail Rev"},{"issue":"1 Pt 2","key":"10.1016\/j.ecl.2011.01.012_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ecl.2011.01.012_bib23","first-page":"1507","article-title":"Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism","volume":"82","author":"Litchfield","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2011.01.012_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.ph.50.030188.002235","article-title":"Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH","volume":"50","author":"Simpson","year":"1988","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10.1016\/j.ecl.2011.01.012_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0039-128X(94)00010-A","article-title":"Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis","volume":"60","author":"Dluhy","year":"1995","journal-title":"Steroids"},{"issue":"6357","key":"10.1016\/j.ecl.2011.01.012_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A\u00a0chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.ecl.2011.01.012_bib27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM198110223051706","article-title":"Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism","volume":"305","author":"Ganguly","year":"1981","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2011.01.012_bib28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jcem-71-5-1151","article-title":"Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism","volume":"71","author":"Ulick","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3 Pt 2","key":"10.1016\/j.ecl.2011.01.012_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.HYP.38.3.688","article-title":"Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives","volume":"38","author":"Mosso","year":"2001","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ecl.2011.01.012_bib30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jcem-59-5-1022","article-title":"Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism","volume":"59","author":"Gomez-Sanchez","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2011.01.012_bib31","first-page":"873","article-title":"The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism","volume":"76","author":"Ulick","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2011.01.012_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A\u00a0new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension","volume":"207","author":"Jonsson","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.ecl.2011.01.012_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0008-6363(96)00069-7","article-title":"Glucocorticoid-remediable aldosteronism","volume":"31","author":"Dluhy","year":"1996","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.ecl.2011.01.012_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/cs0880563","article-title":"Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression","volume":"88","author":"Jamieson","year":"1995","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"10.1016\/j.ecl.2011.01.012_bib35","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","article-title":"Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene","volume":"83","author":"Mulatero","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12 Pt 2","key":"10.1016\/j.ecl.2011.01.012_bib36","first-page":"1610","article-title":"Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I","volume":"13","author":"Stowasser","year":"1995","journal-title":"J\u00a0Hypertens"},{"issue":"10","key":"10.1016\/j.ecl.2011.01.012_bib37","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1210\/jcem.86.10.7920","article-title":"Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1\/CYP11B2 gene","volume":"86","author":"Fardella","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2011.01.012_bib38","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jcem.85.9.6834","article-title":"Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension","volume":"85","author":"Stowasser","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852911000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852911000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:34:19Z","timestamp":1760175259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852911000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0889852911000132"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2011.01.012","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid-remediable Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2011.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}